IntroDuctIon

Blood-brain barrier
The blood-brain barrier (BBB) is a dynamic and complex interface between the blood and the central nervous system (CNS). The BBB strictly controls the exchanges between the blood and brain compartments, thereby protecting and maintaining the delicate interstitial environment optimal for neuronal communication. The anatomical structure of the BBB is comprised of a tightly sealed monolayer of brain microvascular endothelial cells (BMVECs) that are characterized by the absence of fenestrations, a low level of pinocytic vesicles and an elaborate junctional complex formed by both tight junctions and adherens junctions 1 . Because of the paracellular impermeability of the brain endothelium, the bidirectional movement of hydrophilic and lipophilic molecules occurs through BBB transport systems. For instance, glucose transporter-1 (GLUT-1) transports glucose and other hexoses to the brain, whereas members of the ATP-binding cassette family, P-glycoprotein (P-gp) and the multidrug resistance-associated proteins, transport lipophilic molecules, in particular xenobiotics, out of the brain 2, 3 . With the discovery of the BBB in 1885 by Paul Ehrlich 4 and the use of either endogenous or exogenous tracers came an era of exploration of the unique permeability properties of the cerebral endothelial interface in vivo. However, significant advances in our understanding of the molecular mechanisms promoting BBB function did not occur until Joó and Karnushina 5 successfully isolated viable microvessels and generated the in vitro BBB model system from rat brain in 1973. In the following decades, the in vitro BBB model, coupled with various technological platforms and coculture configurations, has become a powerful mainstay tool for studying CNS drug pharmacokinetics, CNS therapeutic targeting, neuroinflammation, neurodegeneration, neuroprotection and neurotoxicity 6 . Isolation of cells from human brain tissue continues to be focused on obtaining microglia, astrocytes and, more recently, neural progenitor cells, whereas only a small effort has been devoted to endothelial cell isolation.
Development of the procedure
The Lymphology Laboratories at the University of Arizona (M. Witte and M. Bernas) has had a long-standing focus on endothelial cells and endothelial cell cultures from both blood and lymphatic vessel sources 7, 8 . Because of a unique collaboration between this laboratory and a neurosurgical colleague (M. Weinand) with access to human brain samples, efforts were undertaken to use our expertise to isolate and culture BMVECs. It was found that most published methods for isolation of BMVECs are time consuming and involve multistep procedures including multiple enzymatic digestions with gradient density centrifugations 9, 10 . Some use more complex methodologies such as glass bead and magnetic separation 11 . Although some of these methodologies have been used with human brain tissue [12] [13] [14] , these techniques have more commonly been applied to tissues from other species, such as rats 9, 15, 16 , mice 17 , porcines 18 or bovines 10, 19 . This may be because of the difficulty in obtaining an adequate amount of human brain tissue for these procedures. As a result, the literature regarding brain endothelial function is largely representative of nonhuman brain endothelium, which prompts caution in the interpretation of data due to species differences, thus highlighting the need for human cells. In addition, in all these methods, the presence of supporting cell types such as pericytes 20 22 . Despite their promising usefulness in research, molecular cytogenetic characterization has recently highlighted complex karyotype changes, thus rendering genetic testing of cell lines advisable before their application in in vitro studies 23 . We approached the isolation from an endothelial standpoint and endeavored to resist the relatively harsh and time-consuming digestions (in our study, we found that enzyme digestions can negatively affect endothelial cell viability) while also eliminating density centrifugations. Goldstein et al. 24 did not use enzyme digestion (retaining density centrifugations) for the isolation of microvascular capillaries for metabolic studies, and we incorporated their methods into our procedure. Starting from 1990, we undertook studies to isolate microvascular capillaries from human temporal lobe brain samples removed during operations to control intractable epilepsy without enzymatic digestion. Using simple unit gravity separation in tissue culture medium, we could easily and quickly complete the isolation and initiation of cell cultures in the tissue culture hood. These early efforts were successful and the cells were used for a variety of multi-institutional collaborative experiments focusing on cocaine and HIV-1 effects on the BBB [25] [26] [27] [28] [29] . Although the method was successful, we encountered difficulty with contaminating cells and with reproducibility, requiring a large number of samples. We therefore reinstituted some of the digestion methods and centrifugations in an effort to improve the procedure. These refinements were successful 30 and are still in use by other investigators 31 . However, we were still troubled by the amount of time, effort and brain tissue that the procedure required. We also had observed that the enzymatic steps could harm endothelial cells if they are used for too long or are too harsh in the procedures. Thus, we reworked the procedure by eliminating enzymatic treatment and density centrifugations. We added an improved method to isolate microvascular fragments by adding a simplified tissue disruption technique, using size exclusion and inclusion with polyester membranes from another endothelial cell isolation procedure in place at the University of Arizona (J. Hoying) 32 .
New procedure and characterization of BMVECs
We have developed a protocol for a reproducible, consistent, economical and simplified isolation/culture of human BMVECs (HBMVECs; Fig. 1 ) that can be implemented in any laboratory with minimal equipment and accessories. Human brain samples can be obtained, after informed consent and institutional review board (IRB) ethical approval, from discarded temporal lobe tissues removed from patients with intractable epilepsy undergoing neurosurgical operative procedures (removal of hippocampal epileptogenic foci). The procedure can be completed in approximately 2.5 h with readily visible endothelial cell clusters after 8-10 d. As seen by phase-contrast microscopy ( Fig. 2) , it is necessary to allow culture expansion to occur for about 1 month to achieve confluency. After confluence is reached, characterization to evaluate the purity of the cell population can be undertaken. To confirm the endothelial phenotype, we can examine several endothelial cell markers by immunohistochemistry with cells grown on coverslips using standard methods (Figs. 3 and 4) , provided in Supplementary Method (see also Supplementary Table 1 ). Markers such as von Willebrand factor (vWF), and especially GLUT-1, are distinctively expressed in these BMVECs. To determine the degree of nonendothelial cell contamination, we can use the widely used pericyte marker α-smooth muscle actin (α-SMA) (Fig. 3) . The formation of the 'physical barrier' by HBMVECs, which acquires the attributes required for modeling of the BBB in vitro, relies on the expression of the proteins present in the tight junction complex. Proteins found at tight junctions, such as the cytosolic zonula occludens (ZO)-1 and ZO-2, the transmembrane occludin, claudin-5 and junction adhesion molecule (JAM)-2, and adherent junction proteins such as β-catenin, are prominently expressed (Figs. 4 and 5) . In addition, caveolin-1, a marker of the cell vesicular transport machinery, and the efflux protein P-gp are also expressed (Fig. 4) . Confluent monolayers of HBMVECs present a high transendothelial electric resistance (TEER) that characterizes these brain-specific endothelial cells (Fig. 6) . TEER enables direct evaluation of an experimental condition that may induce barrier 'tightness' or 'leakiness'. TEER measurements can be acquired with various technologies, including the Electrical Cell-Substrate Impedance Sensing (ECIS) system from Applied Biophysics (Fig. 6a) .
The system works by using the free ions in the culture media, which are then used to generate an AC current flow between an electrode and counterelectrode located in specialized tissue culture arrays. The instrument continuously measures complex impedance, providing readouts for impedance, resistance and capacitance. Typical TEER readings from a low-passage culture of HBMVECs plated at 1 × 10 4 on type I collagen-coated electrode arrays (8W10E + Cultureware array; Applied Biophysics) and monitored (at 1-h intervals using 1,000-Hz AC signal settings) until monolayer confluence and barrier formation occurs are shown (Fig. 6b) . Once the steady-state TEER is reached, the barrier can be evaluated in its response to a particular stimulus and the change from normalized resistance values of HBMVECs can be recorded (Fig. 6c) .
Validation, replication and use
As a demonstration of its validation, simplicity and transportability, this protocol, which was initially developed (more than 50 samples) at the University of Arizona, Tucson, Arizona, USA, has recently allowed for a rapid implementation of HBMVEC cultures in a Portuguese laboratory. Moreover, confluent monolayers resulting from this procedure can be sent from the laboratory where the cells were isolated to other laboratories, rendering the application of the in vitro model of the BBB feasible worldwide. Although we have not analyzed each isolation using all the methods for comparison, this improved technique has been successful in obtaining microvascular endothelial cells from every sample and shows low intersample variations in terms of the profile and expression of junctional proteins. For example, cultures obtained from three resections showed a similar expression profile for transmembrane (occludin and claudin-5) and cytoplasmic (ZO-1 and ZO-2) tight junction proteins (Fig. 5a ).
An expanded gene expression analysis of proteins involved in junctional complexes (ZO-1; ZO-2; occludin; claudin-1, -3 and -5; and JAM-2) confirms the presence and also a similar degree of expression of various HBMVEC isolates (Fig. 5b) . The HBMVECs generated from this procedure have been used for in vitro modeling of the BBB for studies of neuroinflammation and disease processes (including HIV-1), substance abuse research (alcohol, cocaine and methamphetamine) and CNS drug delivery [33] [34] [35] [36] [37] [38] [39] . , using antibodies against occludin, claudin-5, zonula occludens (ZO)-1 and ZO-2 (note: Na + /K + ATPase α1 and β-actin were used as internal/ loading controls). (b) Gene expression profile of tight junction proteins from donors in a. Total RNA was isolated using the RNAqueous-4PCR kit (Ambion) and RNA purity and concentration were determined with a NanoDrop ND-1000 spectrophotometer (Thermo Fisher Scientific). Conversion to cDNA was performed by reverse transcription using 2 µg of total RNA with the High-Capacity cDNA Reverse Transcription Kit (ABI). The cDNA (diluted 1:20) template was then mixed with both the TaqMan Universal PCR Master Mix (ABI) and the corresponding human TaqMan Gene Expression Assay (CLD1: Hs01076359_m1, CLD3: Hs00265816_s1, CLD5: Hs01561351_m1, OCC: Hs00170162_m1, ZO-1: Hs01631876_m1, ZO-2: Hs00910541_m1 and JAM-2: Hs00221894_m1 from ABI) according to the manufacturer's instructions; for internal controls, the human TaqMan Gene Expression Assays for GAPDH and RPLPO (ABI) were also used. qPCR was performed on an ABI StepOnePlus Real-Time PCR System. Raw data were analyzed with DataAssist software (ABI) using the ∆-∆C t method (relative quantification). Results are expressed in relative gene expression levels (fold) compared with a HEK293 control sample. CLD, claudin; OCC, occludin; JAM, junction adhesion molecule. 
MaterIals
REAGENTS
2| Prepare both IM and isolation-supplemented medium (ISM) (see REAGENT SETUP).
HBMVec isolation and culture • tIMInG 2 h 30 min 3| Maintain IM and ISM at 37 °C in a water bath.
4|
Collect the brain sample in a 100-mm tissue culture dish containing ~5 ml IM (Fig. 1a) .  crItIcal step To avoid contamination with microorganisms, it is recommended that processing of the tissue should be performed in a class II biosafety cabinet using sterile reagents.
5|
Carefully remove meninges and visibly large vessels, using sterilized surgical forceps and a dissecting stereomicroscope to facilitate visualization (Fig. 1b) .
6|
Fragment tissue using repeated titration with sterile pipettes of 25, 10 and 5 ml, until the sample can be passed easily back and forth through the 5-ml pipette (Fig. 1c,d ).
Isolation medium (IM) For 100 ml medium, combine 10 ml FBS, 1 ml glutamax, 1 ml antibiotic-antimycotic and 88 ml DMEM-F12, and filter through a 0.2-µm filter. Store at 4 °C for up to 1 week. Isolation-supplemented medium (ISM) For 100 ml medium, combine 10 ml FBS, 1 ml glutamax, 1 ml antibiotic-antimycotic, 2 ml ECGS (50 µg ml 7| Place a 500-µm polyester screen (large enough to overlap) over a 100-mm noncoated Petri dish. The membrane is strong enough to not require a wire backing. Wet the screen with ~5 ml IM.  crItIcal step Always practice proper sterile cell culture technique to avoid contamination. ? trouBlesHootInG 8| Pipette the sample onto the polyester screen by starting from the center and working your way out without pushing the sample through the screen (Fig. 1e) . Wash the screen with ~10 ml IM. This step eliminates larger nondissociated tissues that will not pass through the membrane. These tissues may contain some microvascular fragments, but their inclusion in the culture initiation procedure greatly reduces the establishment and purity of the endothelial cultures.  crItIcal step Perform this step quickly to avoid drying out the polyester screen.
9| Discard the polyester screen and large chunks and preserve the pass-through fluid.
10| Place a sterile wire frame on a sterile, noncoated 100-mm Petri dish and then place a sterile 30-µm polyester screen on top. Wet the screen with ~5 ml IM.
? trouBlesHootInG
11|
Pipette the collected pass-through fluid (from Step 9) onto the 30-µm nylon screen. Start from the center and work in a circle and do not try to push the sample through the membrane (Fig. 1f) . Wash with ~10 ml IM.  crItIcal step Perform this step quickly to avoid drying out the nylon screen.
12|
Open another Petri dish and using an additional 10 ml IM in a serological pipette, hold and fold the screen from Step 11 and wash the isolated fragments off the membrane into the new noncoated dish (Fig. 1g) . Repeat with ~5 ml IM.  crItIcal step Use caution, as this step could potentially introduce microbial contaminants to the preparation. Do not use a coated or tissue culture-prepared dish to prevent adherence of fragments. This filtration step washes through red blood cells that are known to inhibit endothelial cell cultures as well as any other single or groups of cells less than 30 µm that are not microvascular vessel isolates.
13|
Transfer the medium containing all microvascular fragments washed off the membrane in Step 12 into a 50-ml conical tube and centrifuge at 400 r.p.m. (~30g) for 10 min (Fig. 1h) .
14|
Discard the supernatant and resuspend the pellet in 1 ml ISM.
15|
Transfer to a collagen I-coated T-25 flask. Gently shake to ensure coverage of the flask. Allow for attachment of microvessel fragments by placing in the incubator for ~1 h.
16|
Carefully introduce an additional 3 ml ISM to the T-25 flask (Fig. 1i) and, without shaking, move to the incubator. ? trouBlesHootInG Filters (steps 7 and 10) Polyester screens used in Steps 7 and 10 should be discarded after use to avoid clogging and possible contamination in future cultures.
contamination (step 17)
Bacteria and fungi can be identified by phase-contrast microscopy. Pericytes, which can be present in HBMVEC cultures, can be identified by phase-contrast microscopy and by labeling with markers such as α-SMA. Although contamination by astrocytes or microglia has not been observed, these cells can be identified by immunohistochemical labeling with markers such as glial fibrillary acidic protein and CD11b, respectively. These cells do not show the cobblestone appearance of endothelial cells and can be phenotypically identified by phase-contrast microscopy.
cell growth (step 18)
A starting tissue volume of 5-10 mm 3 will generally yield one T-25 (0.5 to 1 × 10 6 cells) flask, whereas each successive increase of 5-10 mm 3 in starting tissue will yield an additional flask. As the fragments are not amenable to counting, the technician must be familiar with the needed density of microvessel fragments to initiate culture. In general, this will be approximately one vessel fragment per 10× field examined, but individual laboratories will vary. Depending on the density of seeding, it is possible that cells may not yet be visible after 2 weeks and confluence may be achieved later than 30 d in vitro. To circumvent this time lapse, we can plate cultures starting with even smaller amounts of brain tissue in cell cultureware of smaller surface area (a Petri dish or a well of a culture plate).
antIcIpateD results
The yield of a culture largely depends on the amount of brain tissue available. Typically, from 5-10 mm 3 of fresh tissue, 1 × 10 6 HBMVECs can be collected after 1 month (Fig. 2) . Evaluation of culture purity by analysis of 50 randomly selected fields reveals the presence of 97% HBMVECs and only 3% contaminating pericytes (Fig. 3) . Using this cell culture protocol, we can detect specific markers of tight and adherens junctional proteins (Figs. 4 and 5) , with no need to use barriertightening inducers such as dexamethasone or hydrocortisone. The cells also express the caveolae marker, caveolin-1, as well as the ATP-binding cassette family protein, P-gp (Fig. 4) . Cell culture properties are reproducible, as can be readily assessed by immunofluorescence analysis of GLUT-1, vWF, ZO-1 and β-catenin. Donor-to-donor variability in tight junction profiles can also be evaluated by analysis of protein expression levels using western blot analysis of subcellular fractions ( Fig. 5a ; note β-actin and Na + /K + ATPase α1 as loading controls for cytosol and membrane/organelle fractions, respectively), or by evaluation of mRNA expression levels by quantitative real-time PCR (Fig. 5b) . The CD-31/PECAM-1 endothelial surface marker is present and can be used for characterization, especially in flow cytometry-related applications. However, we caution that the basal surface expression of this marker is low in resting HBMVECs and that there is a small donor-to-donor variability (unpublished observations). Cultures can be passaged approximately 3-4 times before phenotypic, cell culture purity, and barrier properties are affected, as inferred from the analysis of markers of endothelial cells (GLUT-1, vWF), pericytes (α-SMA) and junction proteins (ZO-1 and β-catenin) by immunofluorescence, as well as of TEER measurement by the ECIS system or STX2 electrode (World Precision Instruments). Cells have been successfully frozen and recovered; however, this does not extend the useful number of passages. Human brain microvascular endothelial cells isolated by the present protocol form a barrier, as indicated by the TEER increase over time, until resistance reaches a steady state with the characteristic high TEER values and no longer fluctuates beyond ±0.1 normalized resistance (subsequent values divided by initial values), as measured by the ECIS 1600R system (Fig. 6a) .
Absolute TEER values for HBMVEC monolayers can be expected above >1,000 Ω when using the 8W10E + Cultureware array with an AC frequency setting of 1,000 Hz. Although curve trends and relative TEER should be comparable across the various types of arrays available (i.e., 8W1E, 8W10E and 8W10E + ), it is important to note that broad differences in absolute TEER will be observed between arrays. For example, 8W10E + contains eight wells, with each well featuring 40 circular microelectrodes (each electrode 10 − 4 cm 2 ), whereas 8W1E contains a single microelectrode per well, which can result in absolute TEER values that are 10 times higher than those observed for 8W10E + . Steady state may be achieved in 8 d as shown in Figure 6b ; however, this greatly depends on HBMEC density at the time of cell plating. Once the HBMEC has reached steady state, cells can be treated accordingly. Figure 6c shows the response of the endothelial barrier after exposure to a high concentration of lysophosphatidic acid (LPA); the precipitous decrease in TEER (Fig. 6c) indicates a disruption or 'leakiness' to the barrier. Conversely, the introduction of dexamethasone will generate a 'tightening' of the barrier and increase resistance gradually over time (data not shown). coMpetInG FInancIal Interests The authors declare no competing financial interests.
